RudaCure held its company-wide New Year ceremonia at the Seoul office on the first Monday of January 2025.
At the ceremonia, CEO Yongho Kim declared preparations for IPO and presentó goals including system reorganization for IPO, tecnología advancement, successful progresoion of ongoing RCI001 ensayo clínicos to the next phase, transferencia de tecnología through non-clinical toxicity studies for pain drug RCI002, and successful PoC for farmacéutico veterinario RCI001AH.
Celebrating the 7th anniversary of la empresa's founding in 2025, the team celebrated the promotion of Assistant Manager Young-ah Ku to Manager and staff member Dongho Kwak to Assistant Manager. For outstanding resultados durante los últimos year, Seunghyuk Choi was premioed as Outstanding Employee, and Assistant Manager Chanhee Choi fue seleccionada como Model Employee for exemplary conduct.
We wish all RudaCure empleados a prosperous 2025 filled with great logros and hope it will be a year of meaningful crecimiento.
